Caspofungin vs Fluconazole for Invasive Fungal Disease Among Young Patients With Acute Myeloid Leukemia
This randomized trial compares the effect of prophylactic caspofungin vs fluconazole on invasive fungal disease among patients between the ages of 3 months to 30 years with acute myeloid leukemia.
Source: JAMA - Category: General Medicine Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancidas | Caspofungin | Fluconazole | General Medicine | Leukemia